Shareholders' Equity and Capital Stock - Schedule of outstanding warrants (Details) - $ / shares |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Shareholders Equity and Capital Stock | |||
| Exercise price | $ 1.5 | $ 1.5 | $ 1.46 |
| Number of warrants | 38,273,500 | 39,041,000 | 55,417,500 |
| Weighted- average remaining contractual life (years) | 1 month 6 days | ||
| Exercise price $1.50 | |||
| Shareholders Equity and Capital Stock | |||
| Exercise price | $ 1.5 | ||
| Number of warrants | 38,273,500 | ||
| Weighted- average remaining contractual life (years) | 1 month 6 days | ||
| Expiry | Feb. 21, 2026 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Details
|